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Membrane biophysicsDuring apoptosis, a number of physical changes occur in the cell membrane including a gradual increase in
permeability to vital stains such as propidium iodide. This study explored the possibility that one consequence
of membrane changes concurrent with early modest permeability is vulnerability to degradation by secretory
phospholipase A2. The activity of this hydrolytic enzyme toward mammalian cells depends on the health of
the cell; healthy cells are resistant, but they become susceptible early during programmed death. Populations
of S49 lymphoma cells during programmed death were classiﬁed by ﬂow cytometry based on permeability to
propidium iodide and susceptibility to secretory phospholipase A2. The apoptotic inducers thapsigargin and
dexamethasone causedmodest permeability to propidium iodide and increased staining bymerocyanine 540,
a dye sensitive to membrane perturbations. Various secretory phospholipase A2 isozymes (human groups IIa,
V, X, and snake venom) preferentially hydrolyzed the membranes of cells that displayed enhanced
permeability. In contrast, cells exposed brieﬂy to a calcium ionophore showed the increase in cell staining
intensity by merocyanine 540 without accompanying uptake of propidium iodide. Under that condition, only
the snake venom and human group X enzymes hydrolyzed cells that were dying. These results suggested that
cells showing modest permeability to propidium iodide during the early phase of apoptosis are substrates for
secretory phospholipase A2 and that speciﬁcity among isoforms of the enzyme depends on the degree to
which the membrane has been perturbed during the death process. This susceptibility to hydrolysis may be
important as part of the signal to attract macrophages toward apoptotic cells.+1 801 422 0263.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Early attempts at distinguishing apoptotic and necrotic cells often
focused on permeability of the cells to vital stains such as propidium
iodide (reviewed in [1]). The original paradigmwas that necrotic cells
are immediately permeable to the dye while apoptotic cells display a
signiﬁcant temporal delay before they become stained. It was soon
discovered that the latent permeability to propidium iodide during
apoptosis is not an “all or none” phenomenon. Instead, there is a
gradual acceleration of probe uptake that initially produces faint
cellular ﬂuorescence quantiﬁable only by ﬂow cytometry but
eventually culminating in complete staining of the cells [2,3].
Presumably, this gradual acceleration represents alterations to the
structure and dynamics of the cell membrane that progressively
become more pronounced. Although these observations have been
substantiated by several investigators, the focus has been conﬁned to
development of assay methods; determinations of mechanisms and
physiological/pathological consequences have lagged.Another membrane event that occurs during early apoptosis is an
increase in the ability of secretory phospholipase A2 (sPLA2) to
hydrolyze phospholipids and release fatty acids and lysophospholi-
pids from the outer face of the plasma membrane [4–8]. This
interesting relationship between sPLA2 and apoptosis is an extension
of a broader paradigm that healthy cells resist hydrolysis by the
enzymewhereasmembranes of damaged or dying cells are vulnerable
[4–10]. At least some of this enhanced vulnerability to hydrolytic
attack is observed in apoptotic cells that have not yet become fully
stained by propidium iodide [5–8]. Apparently, the increased
susceptibility to hydrolysis also represents alterations to the structure
and dynamics of the cell membrane [6,7,9,11–15]. Biophysical studies
of this phenomenon have yielded some clues as to what these
alterations might involve. Possible candidates include increased lipid
spacing, decreased lipid order, and increased exposure of phospha-
tidylserine on the outer face of the cell membrane [6–8]. Nevertheless,
a complete understanding of the nature of relevant membrane
changes during early apoptosis has not yet been achieved. These
observations raise the question of whether the alterations that permit
hydrolysis by sPLA2 might correspond to those that allow modest
permeability to propidium iodide. Answering that question could
clarify mechanisms involved in controlling sPLA2 activity as well as
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membrane permeability to vital stains during apoptosis.
To address this question, we examined responses to various death
stimuli using ﬂow cytometry to classify populations of cells based on
their intensity of staining with ﬂuorescent probes that detect speciﬁc
membrane properties. The objective was to identify which popula-
tions were most susceptible to enzymatic attack and determine how
those populations related to permeability to propidium iodide and
other physical properties. We included agents that initiated death
through endoplasmic reticulum stress, glucocorticoid receptor stim-
ulation, and calcium loading. Although we compared results using
each of these stimuli, we focused most of our attention on
endoplasmic reticulum stress caused by the calcium ATPase inhibitor
thapsigargin [5,16–18]. Thapsigargin was emphasized because it
induces apoptosis rapidly in S49 cells thereby augmenting the size
of relevant populations bymaintaining high synchrony of cells as they
proceed through the death process. In addition to propidium iodide,
merocyanine 540 was used as a marker of increases in interlipid
spacing and membrane lipid disorder that have been reported to
enable hydrolysis by sPLA2[6–8,19–21]. Exposure of phosphatidylser-
ine was eliminated as a variable by including death stimuli and
incubation times known to result in optimal exposure of the anionic
phospholipid on the extracellular membrane surface [5,22–25].
2. Materials and methods
2.1. Reagents
Secretory phospholipase A2 isoforms were isolated and prepared
as described: monomeric aspartate-49 sPLA2 from the venom of
Agkistrodon piscivorus piscivorus (AppD49) [26], hGIIa [27,28], hGV
[29], and hGX [30]. Thapsigargin was obtained from Enzo (Plymouth
Meeting, PA). Dexamethasone was purchased from Sigma-Aldrich (St.
Louis, MO). Ionomycin, acrylodan-labeled intestinal fatty acid-binding
protein (ADIFAB), propidium iodide and merocyanine 540 were
acquired from Invitrogen (Carlsbad, CA). Dipalmitoylphosphatidyl-
glycerol (DPPG) was obtained from Avanti Polar Lipids (Birmingham,
AL). Multilamellar liposomes were prepared by hydration and vortex
agitation of dried lipid samples at 50 °C as described [31].
2.2. Cell culture and treatment with agents
S49 mouse lymphoma cells were grown in suspension in
Dulbecco's Modiﬁed Eagle Medium at 37 °C (10% CO2) as explained
[32]. Cells were treated in culture with thapsigargin (5 μM, 3–4 h),
dexamethasone (100 nM, 24 h), or equivalent volumes of the drug
vehicle dimethylsulfoxide (DMSO,parallel incubation times,≤0.1%v/v).
The treatment timeswere established through preliminary experiments
as themoment corresponding to optimal hydrolysis of the dying cells by
sPLA2. For experiments, cells were collected by centrifugation, washed,
and suspended (0.4–3.5×106 cells/ml) in a balanced salt medium
(NaCl=134 mM, KCl=6.2 mM, CaCl2=1.6 mM, MgCl2=1.2 mM,
Hepes=18.0 mM, and glucose=13.6 mM, pH 7.4, 37 °C). Treatments
with ionomycin (300 nM)were for 10 min in the balanced saltmedium.
All experiments, treatments, and incubations were conducted at 37 °C.
2.3. Flow cytometry
Washed samples of cells in 200 μl aliquots were incubated for
15 min (or as otherwise indicated in ﬁgure legends) with 10 μM
propidium iodide or 250 nM merocyanine 540. Where indicated,
70 nM sPLA2 was also included. Separate aliquots were incubated
with Alexaﬂuor-labeled annexin (Invitrogen, Carlsbad, CA) as positive
controls to verify exposure of phosphatidylserine, an effect expected
and assumed for all of the treatments used in this study [5,22–25].
Samples were then immediately processed (without ﬁxation) by ﬂowcytometry using a BD FACSCanto ﬂow cytometer (BD Biosciences, San
Jose, CA). An argon laser was used for excitation (488 nm) with
emission assessed using a bandpass ﬁlter at 564–606 nm. The number
of cells containing hypodiploid-staining DNA due to fragmentation
was quantiﬁed by ﬂow cytometry after treatment with Triton X-100
as described [33].
2.4. Hydrolysis
Cell membrane hydrolysis catalyzed by various sPLA2 isozymes
(35–70 nM) was measured by assaying fatty acid release using
ADIFAB (65 nM ﬁnal) as described [8]. Most experiments were
conducted using the AppD49 isozyme as a standard for comparison
to previous studies and because it mimics many general behaviors of
the human enzymes [8]. Key results were then repeated with hGIIA,
hGV, and hGX. These assays were conducted on bulk samples in
photon-counting spectroﬂuorometers (Fluoromax 3, Horiba Jobin
Yvon, Edison, NJ) with magnetic stirring and thermostated at 37 °C by
circulating water baths. Data were gathered in real time during
incubation of the cells with ADIFAB and the indicated sPLA2 isozyme.
Fluorescence emission was acquired by rapid sluing of monochroma-
tor mirrors between two emission wavelengths (excitation=390 nm,
emission=432 and 505 nm, 4 nm bandpass). The amount of fatty
acid released was estimated using the following equation:
GP =
I505−I432ð Þ
I505 + I432ð Þ
ð1Þ
GP stands for generalized polarization, and I505 and I432 are the
ﬂuorescence emission intensities at 505 and 432 nm.
The total amount of hydrolysis possible under the various
experimental conditions was estimated using AppD49 sPLA2. Cells
treated with DMSO, thapsigargin, or dexamethasone were incubated
for 600 s with the enzyme. The maximum displacement in ADIFAB GP
during this incubation period was then divided by the equivalent
value obtained from parallel experiments with cells treated 10 min
with 300 nM ionomycin. Ionomycin renders 100% of S49 cells
vulnerable to hydrolysis by AppD49 sPLA2[6] and was therefore
used as a standard to establish the maximum for normalization.
The initial hydrolysis rate was quantiﬁed for each isozyme by
measuring the displacement in ADIFAB GP during the initial 5 s
(AppD49), 20 s (hGX), or 50 s (hGV or hGIIa) of the hydrolysis time
courses and then dividing that value by the length of the incubation.
The speciﬁc activity of each enzyme preparation was assayed by
likewise assessing the initial hydrolysis rate using DPPG liposomes
(25 μM lipid) as substrate.
3. Results
3.1. Susceptibility to sPLA2 of moderately-permeable cells
S49 lymphoma cells were treated for 3 h with thapsigargin or
control vehicle (DMSO), stained with propidium iodide, and classiﬁed
based on staining intensity by ﬂow cytometry. Fig. 1 illustrates
contour plots of the ﬂow cytometry results. As shown in Fig. 1A, three
distinct populations were identiﬁed in control samples based on their
level of propidium iodide ﬂuorescence intensity (ordinate axis). The
designation “P” refers to those cells staining positive for propidium
iodide. This population was indistinguishable from cells that had been
permeabilized by the detergent Triton-X 100 (not shown). Therefore,
it is assumed to represent cells with permeable membranes. The
negative population (“N”) did not stain with propidium iodide since
the apparent ﬂuorescence intensity was comparable to the back-
ground observed with cells that had never been exposed to the dye. A
third population was labeled “I” for intermediate. The average
staining intensity of this population was about 10 times that of the
Fig. 1. Contour plots of propidium iodide ﬂuorescence and forward light scatter. Cells
were treated with DMSO (panel A) or thapsigargin (panels B–D). Samples were stained
for 10 min with propidium iodide in panel A and ﬂuorescence intensity (“PI Intensity”)
and forward light scatter were assessed for individual cells by ﬂow cytometry. In panels
B–D, cells were stained for 1 min (B), 5 min (C), or 10 min (D) with propidium iodide
prior to immediate ﬂow cytometry. Labels: “N,” negative (same as background); “I,”
intermediate propidium iodide staining; “P,” positive or complete propidium iodide
staining. This ﬁgure is a representative example from three independent experiments.
Fig. 2. Histograms of propidium iodide ﬂuorescence intensity before and after
hydrolysis by sPLA2. Cells were treated with DMSO (panel A) or thapsigargin (panel
B). Samples were stained for at least 10 min with propidium iodide without (black
curves) or with (red curves) AppD49 sPLA2. Fluorescence intensity per cell was
assessed by ﬂow cytometry. For key to labels, see Fig. 1. This ﬁgure is a representative
example from three independent experiments.
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in the negative and positive populations exhibited stable ﬂuorescent
intensities over time. However, for the intermediate population, the
degree of staining increased incrementally over time. The cells shown
in Fig. 1A were representative of typical control samples (84.3%
negative, 11.3% intermediate, 4.4% positive).
A likely interpretation of the intermediate population was
suggested in a study by Vitale [2]. The researchers proposed that it
represents a trait inherent to apoptotic cells—slightly compromised
membranes that have therefore become modestly permeable to
propidium iodide. To examine the applicability of this idea to
apoptotic S49 cells, we monitored the distribution of propidium
iodide staining at different times after introduction of the dye to a
thapsigargin-treated sample. We assumed that if the intermediate
population represented cells with modest permeability, the popula-
tion would gradually migrate along the ﬂuorescence intensity axis of
the contour plot while the negative and positive populations would
remain stable. As shown in panels B–D, the positive population was
clearly deﬁned, contained a greater number of cells than in the control
sample (12% compared to 4%), and remained stable in intensity over
time. Initially, cells staining with low intensity were distributed across
both the negative and intermediate regions (panel B). As time
progressed, a population with higher intensity staining emerged and
migrated along the ordinate indicating that the amount of staining per
cell was increasing. By 10 min, the two populations had resolved into
the negative and intermediate regions.
Fig. 2 shows histograms of ﬂuorescence intensity from an
experiment like that of Fig. 1 for cells incubated without (black
curves) or with (red curves) sPLA2. In control samples (panel A), 10-
min treatment with sPLA2 produced only minor alterations. With
thapsigargin-treated cells (panel B), the effects of hydrolysis by sPLA2
were obvious. The proportion of cells found in the positive peak
tripled. These were accounted for quantitatively by a comparable
reduction in the number occupying the intermediate peak. The
proportion of cells found in the negative population stayed about thesame with a small increase in staining intensity, suggesting a minor
perturbation to those cells, perhaps from modest hydrolysis. This
result suggested that cells in the intermediate peak are a prominent
target of sPLA2.
Fig. 3A represents the evolution of the various populations of
apoptotic cells over time after addition of propidium iodide.
Consistent with the results in Fig. 1, the main change was a time-
dependentmigration of cells from the negative region (black lines and
symbols) to the intermediate region (red). A moderate rise in the
number of cells staining positive was also observed (blue). Panels B
and C demonstrate the effect of sPLA2 on the distribution of
populations over time. The main effect was conversion of the
intermediate population to positive cells, presumably due to mem-
brane damage during hydrolysis. As expected, very little hydrolysis
was detected in untreated control samples (open symbols).
As indicated by the relative areas under the black and red curves in
Fig. 3D, only about 40% of the cells in the intermediate population was
hydrolyzed by sPLA2 (i.e. 22–29% of the total sample). There were at
least two reasons that cells remained in the intermediate population
after addition of sPLA2. First, a subpopulation of the intermediate
group was already fully permeable to propidium iodide but stained
with low intensity because of DNA fragmentation. The existence of
this subpopulation was veriﬁed by addition of Triton X-100 [33].
Obviously, hydrolysis would have had no impact on the intensity of
propidium iodide staining of this subpopulation. We performed
parallel control experiments to quantify the contribution of these
hypodiploid cells to the result. We found that about 10% of the sample
contained fragmented DNA under the conditions of Fig. 3, which
would account for about a fourth of the intermediate cells that did not
change staining intensity after sPLA2 treatment (not shown).
The second reasonwhy the remaining cells in this populationdid not
appear to be hydrolyzed is not clear; however, one cluemay come from
close examination of the histograms shown in Fig. 2. The average
staining intensity for the intermediate population was reduced by an
average of 0.15 logunits after hydrolysis by sPLA2. This effect is shown in
Fig. 3D comparing the residual intermediate subpopulation (red) with
that apparently removed by hydrolysis (blue). This difference between
Fig. 3. Time course of distribution of thapsigargin-treated cells among populations deﬁned by propidium iodide ﬂuorescence intensity before and after hydrolysis by sPLA2. Panel A:
data from three independent experiments such as that shown in Fig. 1 were quantiﬁed at the indicated time points followingmixing with propidium iodide—black, percentage of the
cell sample staining negative for propidium iodide intensity (see ﬁeld marked “N” on Fig. 1); red, intermediate for propidium iodide (“I” on Fig. 1); blue, propidium iodide positive
(“P” on Fig. 1). Panel B: The experiments and analysis of panel A were repeated for samples incubated with sPLA2 simultaneously during the propidium iodide staining. Panel C: The
data represent the differences between panels A and B. Open symbols in panels A–C represent data from three control (treated with equivalent DMSO) samples. Panel D: Histograms
of the intermediate cohort corresponding to the last time point from one of the samples in panels A–C for cells without sPLA2 (black), with sPLA2 (red), and the arithmetic difference
between the two (blue). Data were ﬁt by nonlinear regression to a Gaussian function. The brackets represent the 95% conﬁdence intervals for the ﬁtting parameter corresponding to
the mean values. Error bars represent SEM (smaller than the size of the symbols for some of the data).
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was reproducible; the lack of overlap between the 95% conﬁdence
intervals for the respective histogrammeans shown in Fig. 3D was true
for all of the replicate samples in Fig. 3. This result indicates that the
vulnerable subpopulation has a slightly greater permeability to
propidium iodide (about 41% greater) compared to those that remain
resistant. If the intermediate population represents cells with mem-
branes perturbed in a way that makes them susceptible to hydrolysis,
then the data presented here would suggest that the enzyme is quite
sensitive to the magnitude of that perturbation, and only those cells
with sufﬁcient permeability above a narrow threshold are attacked. This
result is reasonable for sPLA2 given the extreme sensitivity of the
enzyme to subtle changes in artiﬁcial membranes [34–36].3.2. Quantiﬁcation of hydrolysis
Experiments parallel to those in Fig. 3 were conducted spectro-
scopically on bulk samples using the ﬂuorescent fatty acid binding
protein ADIFAB to assess the total amount of hydrolysis occurring
during incubation with sPLA2 (Fig. 4A). Consistent with previous
reports, the control cells displayed transient hydrolysis detected by
ADIFAB indicative of a small subset of cells (10–15% of the sample
based on Figs. 2 and 3) that were compromised in culture or during
sample preparation and therefore became vulnerable to the enzyme
[8]. After treatment with thapsigargin, the amount of lipid hydrolyzed
was 52% of the total achievedwhen 100% of the cells are susceptible to
the enzyme (Fig. 4C, green bar).
Previous reports have indicated that the total number of cells
vulnerable to sPLA2 can also be quantiﬁed by counting the number
stained by merocyanine 540 [6,7]. Accordingly, we also assessed
merocyanine 540 staining by ﬂow cytometry (Fig. 4B). Quantitatively,
the number of cells staining brightly formerocyanine 540 in control andthapsigargin samples (violet bars, Fig. 4C) matched the percentage
hydrolyzed (green; see statistical details in the legend to Fig. 4).
3.3. Comparison between hydrolysis and propidium iodide uptake for
various inducers of cell death
The purpose for obtaining these two estimates of the number of
cells vulnerable to enzymatic attack was to compare to the propidium
iodide ﬂow cytometry results and identify those populations of cells
likely to be targets for sPLA2. For control samples and those treated
with thapsigargin, the positive (blue) and intermediate (red)
populations were adequate to account for the amount of hydrolysis
and the apparent numbers of susceptible cells (Fig. 4C). As predicted
by the data in Fig. 3D (red curve), the amount of hydrolysis was less
than the sum of the intermediate and positive populations (pb0.001).
In contrast, cells treated with dexamethasone exhibited a greater
amount of hydrolysis than could be explained by ﬂow cytometry
assessments of merocyanine 540 ﬂuorescence or PI permeability
(pb0.01). This result implies that either there is a greater amount of
lipid hydrolyzed per cell, or some of the negative propidium iodide
population (gray) is hydrolyzed at a rate low enough that it does not
produce enhanced permeability to propidium iodide. One way in
which the ﬁrst of these possibilities could be realized is that cells
treated with dexamethasone, but not thapsigargin or ionomycin, may
break into fragments during hydrolysis that exposes additional intra-
cellular membranes to sPLA2. Further experiments will be required
to resolve this difference and to identify the extent to which it is a
common feature among various apoptotic stimuli.
Cells induced to die by brief treatment (10 min) with a calcium
ionophore, ionomycin, also behaved differently. In this case, all the
cells were vulnerable to the enzyme and stained brightly for
merocyanine 540 as reported previously [6]. However, only about
30% of the cells sorted into the positive or intermediate propidium
Fig. 4. Comparison of compartment sizes assessed by various methods for cells treated
with thapsigargin, dexamethasone or ionomycin. Panel A: Time proﬁle of cell
membrane hydrolysis by AppD49 sPLA2 (added at dotted line) for control (DMSO)
cells (black) and cells treated with thapsigargin (red). Hydrolysis was assayed by
ADIFAB ﬂuorescence as explained in Materials and methods. Panel B: Histograms of
merocyanine 540 staining resolved by ﬂow cytometry for cells treated with DMSO
(black) or thapsigargin (red). Panel C: Cell compartment sizes were estimated by
ﬂuorescence spectroscopy or ﬂow cytometry and normalized tomaxima as explained in
Materials and methods. Green bars: total amount of lipid hydrolyzed by AppD49 sPLA2
in 600 s (spectroscopy of ADIFAB, as in panel A). Violet bars: number of cells staining
brightly for merocyanine 540 (ﬂow cytometry, as in panel B). Blue, red, and gray bars:
number of cells staining positive, intermediate, and negative for propidium iodide (ﬂow
cytometry as in Figs. 1–3). Error bars represent SEM (n=3–42). The three sets of
observations representing hypothesized sPLA2-susceptible cohorts (green, violet, and
blue+red) were analyzed by two-way analysis of variance followed by a Bonferroni
post test for DMSO, thapsigargin, and dexamethasone treatments. The cohorts for
ionomycin were not analyzed in this manner because the values were used as
normalization standards for the other measurements, which would bias the ionomycin
means for statistical comparisons. The overall effect of treatment was signiﬁcant
(pb0.0001, 49% of the total variation) but not the overall effect of measurement type
(0.06% of the total variation). A signiﬁcant interaction was detected (pb0.0001, 12% of
the total variation) suggesting that differences among measurements exist for one or
more of the treatments. The post test revealed three sources of the interaction: For
thapsigargin, the ﬂow cytometry (blue+red) cohort was statistically different from
hydrolysis detected by ADIFAB (pb0.001). For dexamethasone, both merocyanine 540
and propidium iodide ﬂow cytometry results were statistically signiﬁcant compared to
hydrolysis (pb0.01).
Fig. 5. Comparison of initial hydrolysis rates catalyzed by snake venom and human
sPLA2 isoforms among cells treated with DMSO, thapsigargin, dexamethasone, or
ionomycin. Hydrolysis was measured by ADIFAB ﬂuorescence as in Fig. 4A for cells
treated as indicated. The initial rate was quantiﬁed as described in Materials and
methods. Panel A: AppD49; panel B: hGX; panel C: hGV; panel D: hGIIa. For the AppD49,
hGX, and hGIIa isozymes, the results were signiﬁcant by one-way analysis of variance
(pb0.008). As indicated by Dunnett's post-test, the following treatments were
statistically different from the corresponding DMSO controls (pb0.05): AppD49—
dexamethasone and ionomycin, hGX—ionomycin, hGIIa—dexamethasone.
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hydrolysis observed with ionomycin-treated samples originates from
cells that exclude propidium iodide completely.3.4. Comparisons among sPLA2 isoforms
To test the potential physiological relevance of these ﬁndings, we
compared the relative abilities of three human isoforms of sPLA2 to
hydrolyze samples using data obtained with the AppD49 enzyme as a
standard. We compared initial rates rather than total hydrolysis
amounts because they more readily resolve quantitative differences
related to enzyme activity. Fig. 5 summarizes the initial rate of
hydrolysis for all four isozymes under various experimental condi-
tions. As suggested by Fig. 4A, the initial rate catalyzed by AppD49
toward thapsigargin-treated cells was similar to that observed for
unhealthy cells in the control sample (pN0.05) even though the total
available substrate was very different (Fig. 5A). Dexamethasone
induced susceptibility to sPLA2 at a slightly higher initial rate that was
distinguishable from that observed toward damaged cells in the
control sample (pb0.05). As shown in prior studies, the rate toward
ionomycin-treated samples was much greater than with any of the
other conditions (pb0.01 compared to DMSO) [6,8]. A similar pattern
was obtained with the hGX isoform toward the weakened population
in control samples and toward cells treated with the various inducers
of cell death (Fig. 5B). In this case, only the ionomycin group was
statistically different from the control group (pb0.01). In contrast to
the results with the AppD49 and hGX isozymes, the hGIIa and hGV
isozymes generally showed a different pattern with more obvious
differences in the rate of hydrolysis between control and apoptotic
samples (thapsigargin and dexamethasone) but diminution of the
rate toward samples incubated brieﬂy with ionomycin (Fig. 5C and D;
see legend for statistical details). As explained for the AppD49
isoform, the amount of lipid hydrolyzed in the various treatment
groups was always much greater than observed in the control sample
(reﬂecting the larger number of cells participating in biochemically-
programmed death) even though the initial rate was sometimes
comparable [6].
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has been reported previously [12,37–39] and probably relates to the
absence of tryptophan at its interfacial binding surface [12,27,40]. This
differencewas not due to low activity of the enzyme preparation since
hGIIa was themost active of the four toward the DPPG liposomes used
as a positive control (AppD49=0.05 GP units∙s−1, hGIIa=0.08 GP
units∙s−1, hGV=0.005 GP units∙s−1, hGX=0.01 GP units∙s−1). This
dichotomy between hGIIa activities toward liposomes versus apopto-
tic cells probably reﬂects the much higher density of negative charge
on the liposome compared to that achievable in S49 cells [10].
4. Discussion
The data in this study argue strongly that one consequence of the
modest increase in membrane permeability detected by propidium
iodide as an intermediate-staining population is enhanced suscepti-
bility to hydrolysis by sPLA2. Moreover, this enhanced susceptibility is
likely to have physiological signiﬁcance because several sPLA2
isoforms present in human plasma responded to these early apoptotic
cells (Fig. 5). In contrast, cells dying by ionophore treatment showed
two important deviations from this pattern. First, the cells did not
display a sizeable intermediate-staining propidium iodide population
even though they stained brightly with merocyanine 540 and were
aggressively attacked by AppD49 and hGX sPLA2. Second, the
ionophore-treated cells were hydrolyzed at a much lower rate by
hGV and hGIIa sPLA2. This second observation was reported
previously and raised the question of whether there might be
differences in physical properties of the membranes of apoptotic
and ionophore-treated cells that explain this apparent speciﬁcity of
the isozymes [8]. The presence of anionic lipids such as phosphati-
dylserine on the membrane surface and enhanced spacing of bilayer
lipids, two properties known to be relevant to the activity of these
enzymes, were excluded as candidates since both are expressed more
completely in ionophore-treated cells than in those undergoing
apoptosis (Fig. 4 and Ref. [8]). However, the relationship between
hydrolysis and the intermediate-staining propidium iodide popula-
tion discovered here (Figs. 4 and 5) is a match with the prior
observations and may explain the speciﬁcity of hGV and hGIIa sPLA2
isoforms toward apoptotic cells.
This result begs the interesting question: what is the molecular
source of the intermediate-staining population, and why does it
appear to relate to enhanced enzymatic activity of hGIIa and hGV
sPLA2 isoforms? An attractive possibility is that both events are
produced by lipid oxidation. This idea stems from three published
observations. First, lipid peroxidation appears to occur during
apoptosis, perhaps catalyzed by cytochrome c oxidase released from
mitochondria [41–44]. Second, studies with artiﬁcial bilayers suggest
that lipid oxidation can perturb the physical properties of membranes
in ways that enhance their permeability [42,45–47]. Third, mem-
branes containing oxidized lipids aremore vulnerable to hydrolysis by
sPLA2, especially the hGIIa isozyme [48–52].
A second possibility relates to studies with artiﬁcial membranes
demonstrating that ﬂuctuations caused by changes in membrane order
and ﬂuidity can permit charged molecules like propidium iodide to
temporarily traverse the bilayer [53–57]. The increased staining of the
membrane by merocyanine 540 (Fig. 4 and Ref. [6,7]) probably also
represents changes of that nature [19–21,31,58]. Thus, itmay be that the
intermediate propidium iodide population does not represent emer-
gence of an additional membrane physical trait but instead, greater
magnitude of the same perturbations detected by merocyanine 540. In
other words, perhaps merocyanine 540 is sensitive to low levels of
perturbation as perhaps occurswith ionomycin.When the perturbation
escalates to the point that it becomes detectable by propidium iodide,
such as during apoptosis, there is no additional staining bymerocyanine
540 because the intensity was already maximal at a weaker perturba-
tion. If this is true, then the differences among isoforms with respect tomembrane physical properties would be quantitative rather than
qualitative and could be summarized as follows.
1. Cells that are negative for both merocyanine 540 and propidium
iodide were not attacked by any of the sPLA2 isoforms studied here.
2. Cells that are weakly perturbed, as during ionomycin treatment,
stain brightly by merocyanine 540 but are still negative for
propidium iodide. These cells were good substrates only for the
AppD49 and hGX isoforms.
3. Cells that are more strongly perturbed stain brightly by merocya-
nine 540 and at an intermediate level with propidium iodide. These
cells were observed during apoptosis and were susceptible to all
four isoforms.
4. The cells that are most heavily perturbed are positive for both
propidium iodide and merocyanine 540. A previous study
demonstrates these cells are also hydrolyzed by the various
isozymes, at least during mid-apoptosis [8].
Finally, there is evidence that membrane permeability is enhanced
in a more speciﬁc fashion early during apoptosis via pannexin 1
channels [59]. This rise in permeability allows release of nucleotides
such as ATP and UTP from apoptotic cells. These nucleotides function
as signals to attract macrophages in preparation for clearance of
apoptotic remnants [59,60]. Whether activation of these channels
accounts for the modest rise in permeability to propidium iodide is
unknown. Other vital stains such as YO-PRO-1 and TO-PRO-3 appear
to be conducted by pannexin channels, but propidium iodide was
reported not to stain cells at a stage of apoptosis when pannexin
channels are open [59]. Unfortunately, the experimental data were
not reported in sufﬁcient detail to allow one to ascertain whether the
more moderate propidium iodide diffusion characteristic of early
apoptotic cells could be explained by pannexin channel activation.
Moreover, it is unclear how pannexin channel activation might relate
directly to increased vulnerability of the membrane to hydrolysis by
sPLA2.
The data in this study suggest the possibility that the temporary
moderate increase in membrane permeability during apoptosis could
have signiﬁcant consequences because these cells can be hydrolyzed
by pro-inﬂammatory enzymes present in the plasma. In general, it is
thought that this kind of problem would be avoided through
elimination of apoptotic cells by macrophages [61–63]. The issue,
then, becomes one of timing. Recent studies have suggested that
macrophage participation involves two signals: a recognition or “ﬁnd-
me” signal followed by an “eat-me” signal [59]. The ﬁrst appears to
involve increases in membrane permeability via the pannexin 1
channel mentioned above [59]. The second is the exposure of
phosphatidylserine on the external face of the cell membrane [64–
67]. Since the hGV and hGIIa isoforms require the presence of
phosphatidylserine in addition to enhanced membrane permeability,
they would not be capable of generating inﬂammatory precursors
until the “eat-me” signal and the resulting protection by phagocytosis.
Therefore, these isoforms are unlikely to produce an untoward
inﬂammatory response. However, as recently demonstrated, the
hGX isozyme actively hydrolyzes the cell membrane during apoptosis
prior to the exposure of phosphatidylserine [8]. Accordingly, the
potential exists for production and release of inﬂammatory fatty acids
and lysophospholipids during apoptosis before the dying cells can be
cleared by macrophages. This scenario may not be a bad thing,
however. Although pannexin channel activation has been proposed as
one mechanism for releasing certain “ﬁnd-me” signals, additional
molecules that fulﬁll the same function have also been reported to be
released during early apoptosis through undetermined means [61–
63]. Among those other signals is lysophosphatidylcholine [68–70]. It
is thus tempting to speculate that hGX sPLA2 may play a major role in
releasing lysophosphatidylcholine as a “ﬁnd-me” signal through
mechanisms described in this study.
1919J. Nelson et al. / Biochimica et Biophysica Acta 1808 (2011) 1913–1920Acknowledgments
The authors express appreciation to Michael Gelb (University of
Washington) and Wonhwa Cho (University of Illinois, Chicago), for
generously providing samples of human sPLA2 isoforms. This work
was supported by the National Institutes of Health (GM073997).
References
[1] Z. Darzynkiewicz, G. Juan, X. Li, W. Gorczyca, T. Murakami, F. Traganos, Cytometry
in cell necrobiology: analysis of apoptosis and accidental cell death necrosis.
Cytometry 27 (1997) 1–20.
[2] M. Vitale, L. Zamai, G. Mazzotti, A. Cataldi, E. Falcieri, Differential kinetics of
propidium iodide uptake in apoptotic and necrotic thymocytes, Histochemistry
100 (1993) 223–229.
[3] L. Zamai, E. Falcieri, G. Marhefka, M. Vitale, Supravital exposure to propidium
iodide identiﬁes apoptotic cells in the absence of nucleosomal DNA fragmenta-
tion, Cytometry 23 (1996) 303–311.
[4] G. Atsumi, M. Murakami, M. Tajima, S. Shimbara, N. Hara, I. Kudo, The perturbed
membrane of cells undergoing apoptosis is susceptible to type II secretory
phospholipase A2 to liberate arachidonic acid, Biochim. Biophys. Acta 1349 (1997)
43–54.
[5] K.H. Nielson, C.A. Olsen, D.V. Allred, K.L. O'Neill, G.F. Burton, J.D. Bell, Susceptibility
of S49 lymphoma cell membranes to hydrolysis by secretory phospholipase A(2)
during early phase of apoptosis, Biochim. Biophys. Acta 1484 (2000) 163–174.
[6] R.W. Bailey, E.D. Olson, M.P. Vu, T.J. Brueseke, L. Robertson, R.E. Christensen, K.H.
Parker, A.M. Judd, J.D. Bell, Relationship between membrane physical properties
and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-
induced apoptosis, Biophys. J. 93 (2007) 2350–2362.
[7] R.W. Bailey, T. Nguyen, L. Robertson, E. Gibbons, J. Nelson, R.E. Christensen, J.P.
Bell, A.M. Judd, J.D. Bell, Sequence of physical changes to the cell membrane
during glucocorticoid-induced apoptosis in S49 lymphoma cells, Biophys. J. 96
(2009) 2709–2718.
[8] E.D. Olson, J. Nelson, K. Grifﬁth, T. Nguyen, M. Streeter, H.A. Wilson-Ashworth, M.H.
Gelb, A.M. Judd, J.D. Bell, Kinetic evaluation of cell membrane hydrolysis during
apoptosis by human isoforms of secretory phospholipase A2, J. Biol. Chem. 285
(2010) 10993–11002.
[9] L.B. Jensen, N.K. Burgess, D.D. Gonda, E. Spencer, H.A. Wilson-Ashworth, E.
Driscoll, M.P. Vu, J.L. Fairbourn, A.M. Judd, J.D. Bell, Mechanisms governing the
level of susceptibility of erythrocyte membranes to secretory phospholipase A2,
Biophys. J. 88 (2005) 2692–2705.
[10] H.A. Wilson, J.B. Waldrip, K.H. Nielson, A.M. Judd, S.K. Han, W. Cho, P.J. Sims, J.D.
Bell, Mechanisms by which elevated intracellular calcium induces S49 cell
membranes to become susceptible to the action of secretory phospholipase A2,
J. Biol. Chem. 274 (1999) 11494–11504.
[11] K.B. Best, A.J. Ohran, A.C. Hawes, T.L. Hazlett, E. Gratton, A.M. Judd, J.D. Bell,
Relationship between erythrocyte membrane phase properties and susceptibility
to secretory phospholipase A2, Biochemistry 41 (2002) 13982–13988.
[12] S. Bezzine, J.G. Bollinger, A.G. Singer, S.L. Veatch, S.L. Keller, M.H. Gelb, On the
binding preference of human groups IIA and X phospholipases A2 for membranes
with anionic phospholipids, J. Biol. Chem. 277 (2002) 48523–48534.
[13] A.G. Singer, F. Ghomashchi, C. Le Calvez, J. Bollinger, S. Bezzine, M. Rouault, M.
Sadilek, M. Lazdunski, G. Lambeau, M.H. Gelb, Interfacial kinetic and binding
properties of the complete set of human and mouse groups I, II, V, X, and XII
secreted phospholipases A2, J. Biol. Chem. 277 (2002) 48535–48549.
[14] F.M. Harris, S.K. Smith, J.D. Bell, Physical properties of erythrocyte ghosts that
determine susceptibility to secretory phospholipase A2, J. Biol. Chem. 276 (2001)
22722–22731.
[15] S.K. Smith, A.R. Farnbach, F.M. Harris, A.C. Hawes, L.R. Jackson, A.M. Judd, R.S. Vest,
S. Sanchez, J.D. Bell, Mechanisms by which intracellular calcium induces
susceptibility to secretory phospholipase A2 in human erythrocytes, J. Biol.
Chem. 276 (2001) 22732–22741.
[16] X. Bian, F.M. Hughes Jr., Y. Huang, J.A. Cidlowski, J.W. Putney Jr., Roles of
cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of
apoptosis in S49 cells, Am. J. Physiol. 272 (1997) C1241–C1249.
[17] G.E. Kass, S. Orrenius, Calcium signaling and cytotoxicity, Environ. Health
Perspect. 107 (Suppl 1) (1999) 25–35.
[18] I. Yoshida, A. Monji, K. Tashiro, K. Nakamura, R. Inoue, S. Kanba, Depletion of
intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER
stress and apoptosis in PC12 cells, Neurochem. Int. 48 (2006) 696–702.
[19] D.A. Mower Jr., D.W. Peckham, V.A. Illera, J.K. Fishbaugh, L.L. Stunz, R.F. Ashman,
Decreased membrane phospholipid packing and decreased cell size precede DNA
cleavage in mature mouse B cell apoptosis, J. Immunol. 152 (1994) 4832–4842.
[20] R.F. Ashman, D. Peckham, S. Alhasan, L.L. Stunz, Membrane unpacking and the
rapid disposal of apoptotic cells, Immunol. Lett. 48 (1995) 159–166.
[21] W. Stillwell, S.R. Wassall, A.C. Dumaual, W.D. Ehringer, C.W. Browning, L.J. Jenski,
Use of merocyanine (MC540) in quantifying lipid domains and packing in
phospholipid vesicles and tumor cells, Biochim. Biophys. Acta 1146 (1993)
136–144.
[22] S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M.
LaFace, D.R. Green, Early redistribution of plasma membrane phosphatidylserine
is a general feature of apoptosis regardless of the initiating stimulus: inhibition by
overexpression of Bcl-2 and Abl, J. Exp. Med. 182 (1995) 1545–1556.[23] C. Diaz, A.T. Lee, D.J. McConkey, A.J. Schroit, Phosphatidylserine externalization
during differentiation-triggered apoptosis of erythroleukemic cells, Cell Death
Differ. 6 (1999) 218–226.
[24] A.J. Mazur, D. Nowak, H.G. Mannherz, M. Malicka-Blaszkiewicz, Methotrexate
induces apoptosis in CaSki and NRK cells and inﬂuences the organization of their
actin cytoskeleton, Eur. J. Pharmacol. 613 (2009) 24–33.
[25] H.J. Ahn, Y.S. Kim, J.U. Kim, S.M. Han, J.W. Shin, H.O. Yang, Mechanism of taxol-
induced apoptosis in human SKOV3 ovarian carcinoma cells, J. Cell. Biochem. 91
(2004) 1043–1052.
[26] J.M. Maraganore, G. Merutka, W. Cho, W. Welches, F.J. Kezdy, R.L. Heinrikson, A new
class of phospholipases A2 with lysine in place of aspartate 49. Functional con-
sequences for calcium and substrate binding, J. Biol. Chem. 259 (1984) 13839–13843.
[27] S.F. Baker, R. Othman,D.C.Wilton, Tryptophan-containingmutant of human (group IIa)
secreted phospholipase A2 has a dramatically increased ability to hydrolyze phospha-
tidylcholine vesicles and cell membranes, Biochemistry 37 (1998) 13203–13211.
[28] M. Markova, R.A. Koratkar, K.A. Silverman, V.E. Sollars, M. MacPhee-Pellini, R.
Walters, J.P. Palazzo, A.M. Buchberg, L.D. Siracusa, S.A. Farber, Diversity in secreted
PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to
Apc Min/+ tumorigenesis, Oncogene 24 (2005) 6450–6458.
[29] W.Cho, S.K.Han,B.I. Lee, Y. Snitko, R.Dua, Puriﬁcationandassayofmammaliangroup I
and group IIa secretory phospholipase A2, Methods Mol. Biol. 109 (1999) 31–38.
[30] Y.H. Pan, B.Z. Yu, A.G. Singer, F. Ghomashchi, G. Lambeau, M.H. Gelb, M.K. Jain, B.J.
Bahnson, Crystal structure of human group X secreted phospholipase A2.
Electrostatically neutral interfacial surface targets zwitterionic membranes,
J. Biol. Chem. 277 (2002) 29086–29093.
[31] B.M. Stott, M.P. Vu, C.O. McLemore, M.S. Lund, E. Gibbons, T.J. Brueseke, H.A.
Wilson-Ashworth, J.D. Bell, Use of ﬂuorescence to determine the effects of
cholesterol on lipid behavior in sphingomyelin liposomes and erythrocyte
membranes, J. Lipid Res. 49 (2008) 1202–1215.
[32] H.A. Wilson, W. Huang, J.B. Waldrip, A.M. Judd, L.P. Vernon, J.D. Bell, Mechanisms
by which thionin induces susceptibility of S49 cell membranes to extracellular
phospholipase A2, Biochim. Biophys. Acta 1349 (1997) 142–156.
[33] C. Riccardi, I. Nicoletti, Analysis of apoptosis by propidium iodide staining and
ﬂow cytometry, Nat. Protoc. 1 (2006) 1458–1461.
[34] J.D. Bell, R.L. Biltonen, The temporal sequence of events in the activation of
phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from
Agkistrodon piscivorus piscivorus, J. Biol. Chem. 264 (1989) 12194–12200.
[35] D. Lichtenberg, G. Romero, M. Menashe, R.L. Biltonen, Hydrolysis of dipalmitoyl-
phosphatidylcholine large unilamellar vesicles by porcine pancreatic phospholi-
pase A2, J. Biol. Chem. 261 (1986) 5334–5340.
[36] T. Honger, K. Jorgensen, R.L. Biltonen, O.G. Mouritsen, Systematic relationship
between phospholipase A2 activity and dynamic lipid bilayermicroheterogeneity,
Biochemistry 35 (1996) 9003–9006.
[37] S.A. Beers, A.G. Buckland, R.S. Koduri, W. Cho, M.H. Gelb, D.C. Wilton, The
antibacterial properties of secreted phospholipases A2: a major physiological role
for the group IIA enzyme that depends on the very high pI of the enzyme to allow
penetration of the bacterial cell wall, J. Biol. Chem. 277 (2002) 1788–1793.
[38] B.B. Boyanovsky, N.R. Webb, Biology of secretory phospholipase A2, Cardiovasc.
Drugs Ther. 23 (2009) 61–72.
[39] C.N. Birts, C.H. Barton, D.C. Wilton, Catalytic and non-catalytic functions of human
IIA phospholipase A2, Trends Biochem. Sci. 35 (2010) 28–35.
[40] S.A. Beers, A.G. Buckland, N. Giles, M.H. Gelb, D.C. Wilton, Effect of tryptophan
insertions on the properties of the human group IIA phospholipase A2:
mutagenesis produces an enzyme with characteristics similar to those of the
human group V phospholipase A2, Biochemistry 42 (2003) 7326–7338.
[41] Y.Y. Tyurina, A.A. Shvedova, K. Kawai, V.A. Tyurin, C. Kommineni, P.J. Quinn, N.F.
Schor, J.P. Fabisiak, V.E. Kagan, Phospholipid signaling in apoptosis: peroxidation
and externalization of phosphatidylserine, Toxicology 148 (2000) 93–101.
[42] M.E. Greenberg, X.M. Li, B.G. Gugiu, X. Gu, J. Qin, R.G. Salomon, S.L. Hazen, The lipid
whisker model of the structure of oxidized cell membranes, J. Biol. Chem. 283
(2008) 2385–2396.
[43] V.A. Tyurin, Y.Y. Tyurina, M.Y. Jung, M.A. Tungekar, K.J. Wasserloos, H. Bayir, J.S.
Greenberger, P.M. Kochanek, A.A. Shvedova, B. Pitt, V.E. Kagan, Mass-spectrometric
analysis of hydroperoxy- and hydroxy-derivatives of cardiolipin and phosphatidyl-
serine in cells and tissues induced by pro-apoptotic and pro-inﬂammatory stimuli,
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (2009) 2863–2872.
[44] V.A. Tyurin, Y.Y. Tyurina, P.M. Kochanek, R. Hamilton, S.T. DeKosky, J.S. Green-
berger, H. Bayir, V.E. Kagan, Oxidative lipidomics of programmed cell death,
Methods Enzymol. 442 (2008) 375–393.
[45] D. Yajima, H. Motani, M. Hayakawa, Y. Sato, K. Sato, H. Iwase, The relationship
between cell membrane damage and lipid peroxidation under the condition of
hypoxia-reoxygenation: analysis of the mechanism using antioxidants and
electron transport inhibitors, Cell Biochem. Funct. 27 (2009) 338–343.
[46] M.C. Howland, A.N. Parikh, Model studies of membrane disruption by photo-
generated oxidative assault, J. Phys. Chem. B 114 (2010) 6377–6385.
[47] H.L. Smith, M.C. Howland, A.W. Szmodis, Q. Li, L.L. Daemen, A.N. Parikh, J.
Majewski, Early stages of oxidative stress-induced membrane permeabilization: a
neutron reﬂectometry study, J. Am. Chem. Soc. 131 (2009) 3631–3638.
[48] S. Akiba, R. Nagatomo, M. Hayama, T. Sato, Lipid peroxide overcomes the inability
of platelet secretory phospholipase A2 to hydrolyze membrane phospholipids in
rabbit platelets, J. Biochem. Tokyo 122 (1997) 859–864.
[49] A.A. Korotaeva, E.V. Samoilova, A.A. Pirkova, N.V. Prokazova, The effect of LDL on
the activity of proinﬂammatory secretory phospholipase A2 (IIA) depends on the
degree of their oxidation, Ross. Fiziol. Zh. Im. I. M. Sechenova 95 (2009) 476–483.
[50] A.A. Korotaeva, E.V. Samoilova, A.A. Pirkova, V.A. Ameliushkina, N.V. Prokazova, V.A.
Tkachuk, E.I. Chazov, Opposite effects of native and oxidized lipoproteins on the
1920 J. Nelson et al. / Biochimica et Biophysica Acta 1808 (2011) 1913–1920activity of secretory phospholipase A(2) group IIA, Prostaglandins Other Lipid
Mediat. 90 (2009) 37–41.
[51] A.A. Korotaeva, E.V. Samoilova, G.F. Piksina, N.V. Prokazova, Oxidized phospha-
tidylcholine stimulates activity of secretory phospholipase A2 group IIA and
abolishes sphingomyelin-induced inhibition of the enzyme, Prostaglandins Other
Lipid Mediat. 91 (2010) 38–41.
[52] L.R. McLean, K.A. Hagaman, W.S. Davidson, Role of lipid structure in the activation
of phospholipase A2 by peroxidized phospholipids, Lipids 28 (1993) 505–509.
[53] D. Marsh, A. Watts, P.F. Knowles, Evidence for phase boundary lipid. Permeability
of tempo-choline into dimyristoylphosphatidylcholine vesicles at the phase
transition, Biochemistry 15 (1976) 3570–3578.
[54] E. Freire, R. Biltonen, Estimation of molecular averages and equilibrium
ﬂuctuations in lipid bilayer systems from the excess heat capacity function,
Biochim. Biophys. Acta 514 (1978) 54–68.
[55] H.A. Wilson-Ashworth, A.M. Judd, R.M. Law, B.D. Freestone, S. Taylor, M.K.
Mizukawa, K.R. Cromar, S. Sudweeks, J.D. Bell, Formation of transient non-protein
calcium pores by lysophospholipids in S49 Lymphoma cells, J. Membr. Biol. 200
(2004) 25–33.
[56] D.W. Deamer, J. Bramhall, Permeability of lipid bilayers to water and ionic solutes,
Chem. Phys. Lipids 40 (2006) 167–188.
[57] B. Apellaniz, J.L. Nieva, P. Schwille, A.J. Garcia-Saez, All-or-none versus graded:
single-vesicle analysis reveals lipid composition effects on membrane permea-
bilization, Biophys. J. 99 (2010) 3619–3628.
[58] H.A. Wilson-Ashworth, Q. Bahm, J. Erickson, A. Shinkle, M.P. Vu, D. Woodbury, J.D.
Bell, Differential detection of phospholipid ﬂuidity, order, and spacing by
ﬂuorescence spectroscopy of bis-pyrene, prodan, nystatin, and merocyanine
540, Biophys. J. 91 (2006) 4091–4101.
[59] F.B. Chekeni, M.R. Elliott, J.K. Sandilos, S.F. Walk, J.M. Kinchen, E.R. Lazarowski, A.J.
Armstrong, S. Penuela, D.W. Laird, G.S. Salvesen, B.E. Isakson, D.A. Bayliss, K.S.
Ravichandran, Pannexin 1 channels mediate “ﬁnd-me” signal release and
membrane permeability during apoptosis, Nature 467 (2010) 863–867.[60] F.B. Chekeni, K.S. Ravichandran, The role of nucleotides in apoptotic cell clearance:
implications for disease pathogenesis, J. Mol. Med. 89 (2011) 13–22.
[61] C. Peter, S. Wesselborg, K. Lauber, Apoptosis: opening PANdora's BoX, Curr. Biol.
20 (2010) R940–R942.
[62] C. Peter, S. Wesselborg, M. Herrmann, K. Lauber, Dangerous attraction: phagocyte
recruitment and danger signals of apoptotic and necrotic cells, Apoptosis 15
(2010) 1007–1028.
[63] C. Peter, S. Wesselborg, K. Lauber, Molecular suicide notes: last call from
apoptosing cells, J. Mol. Cell Biol. 2 (2010) 78–80.
[64] M.K. Callahan, P. Williamson, R.A. Schlegel, Surface expression of phosphatidyl-
serine on macrophages is required for phagocytosis of apoptotic thymocytes, Cell
Death Differ. 7 (2000) 645–653.
[65] B. Fadeel, Plasma membrane alterations during apoptosis: role in corpse
clearance, Antioxid. Redox Signal. 6 (2004) 269–275.
[66] S. Krahling, M.K. Callahan, P. Williamson, R.A. Schlegel, Exposure of phosphati-
dylserine is a general feature in the phagocytosis of apoptotic lymphocytes by
macrophages, Cell Death Differ. 6 (1999) 183–189.
[67] B. Verhoven, R.A. Schlegel, P. Williamson, Mechanisms of phosphatidylserine
exposure, a phagocyte recognition signal, on apoptotic T lymphocytes, J. Exp. Med.
182 (1995) 1597–1601.
[68] R.B. Mueller, A. Sheriff, U.S. Gaipl, S. Wesselborg, K. Lauber, Attraction of
phagocytes by apoptotic cells is mediated by lysophosphatidylcholine, Autoim-
munity 40 (2007) 342–344.
[69] K. Lauber, E. Bohn, S.M. Krober, Y.J. Xiao, S.G. Blumenthal, R.K. Lindemann, P.
Marini, C. Wiedig, A. Zobywalski, S. Baksh, Y. Xu, I.B. Autenrieth, K. Schulze-
Osthoff, C. Belka, G. Stuhler, S. Wesselborg, Apoptotic cells induce migration of
phagocytes via caspase-3-mediated release of a lipid attraction signal, Cell 113
(2003) 717–730.
[70] C. Peter, M. Waibel, C.G. Radu, L.V. Yang, O.N. Witte, K. Schulze-Osthoff, S.
Wesselborg, K. Lauber, Migration to apoptotic “ﬁnd-me” signals is mediated via
the phagocyte receptor G2A, J. Biol. Chem. 283 (2008) 5296–5305.
